Polygenic scores calculated by TGen researchers reflect both long life and healthContinue reading
Category Archives: AZBio News
Taking a Closer Look at Pulmonary Fibrosis Genetics
Study is the first to map variations in gene regulation at the cell type level throughout the lung
C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research
TUCSON, Ariz., March 28, 2024 — Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of a groundbreaking model-based Clinical Trial Simulator (CTS), specifically designed to improve design of efficacy studies for potential therapies for Duchenne muscular dystrophy (DMD). This pioneering Drug Development Tool is set to positively impact the medical research community by significantly optimizing clinical trial design.Continue reading
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
Results indicate potential of a minimally invasive screening tool to detect most common form of Esophageal Cancer, a highly treatable cancer if caught early Continue reading
UArizona scientists pinpoint anorexia’s neurologic origins
The discovery, led by Haijiang Cai, an associate professor in the Department of Neuroscience, was observed in mice, but the findings could lead to human drug treatments.Continue reading
Match Day reveals next paths in future physicians’ careers
Fourth-year students at the College of Medicine – Tucson and the College of Medicine – Phoenix learned where their journey to become physicians will take them next.Continue reading
AZBio Members – Apply before April 19th for MTC Flex Pass Savings
The Medtech Conference, October 15-17, 2024 in Toronto, Canada features the new Medtech campus, thousands of medtech professionals and innovative companies, a curated cross-cutting education program, invaluable access to key decision makers, next-level technology and efficient networking. Join us to gain insights, connections, and advancements to propel your company forward in the dynamic medical technology landscape.Continue reading
Breakthrough Results of NIH-Sponsored Study of Syn-One Test® as a Skin-Based Diagnostic Tool for Parkinson’s Disease and Related Disorders Published in the Journal of the American Medical Association
- Study demonstrates alpha-synuclein biomarker can be detected in 93-100% of patients with clinically defined pathologies using simple skin biopsy procedure
- Syn-One Test addresses key unmet needs by supporting accurate diagnoses for patients and serving as a reliable biomarker for clinical trials